Publications and communications of Frédéric Ooms

Ooms, F. (2023). The Entrepreneurial Cognitive Flexibility. A Study at the Intersection of Neuroscience and Entrepreneurship [Doctoral thesis, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/301474

Obschonka, M., Grégoire, D. A., Nikolaev, B., Ooms, F., Lévesque, M., Pollack, J. M., & Behrend, T. S. (2024). Artificial Intelligence and Entrepreneurship: A Call for Research to Prospect and Establish the Scholarly AI Frontiers [letter to the editor]. Entrepreneurship: Theory and Practice. doi:10.1177/10422587241304676

Ooms, F., Annen, J., Panda, R., Cecconi, B., Surlemont, B., & Laureys, S. (November 2024). Entrepreneurial neuroanatomy: Exploring gray matter volume in habitual entrepreneurs. Journal of Business Venturing Insights, 22, 00480. doi:10.1016/j.jbvi.2024.e00480

Ooms, F., Annen, J., Panda, R., Meunier, P., Tshibanda, L., Laureys, S., Pollack, J. M., & Surlemont, B. (March 2024). Advancing (Neuro)Entrepreneurship Cognition Research Through Resting-State fMRI: A Methodological Brief. Entrepreneurship: Theory and Practice, 48 (2), 719-741. doi:10.1177/10422587231170217

Ooms, F., Surlemont, B., Annen, J., Panda, R., & Laureys, S. (August 2023). The Habitual Entrepreneur Brain – A Voxel Based Morphometry Study. Academy of Management Proceedings, 2023 (1). doi:10.5465/amproc.2023.142bp

Hoveyda, H. R., Fraser, G. L., Zoute, L., Dutheuil, G., Schils, D., Brantis, C., Lapin, A., Parcq, J., Guitard, S., Lenoir, F., Bousmaqui, M. E., Rorive, S., Hospied, S., Blanc, S., Bernard, J., Ooms, F., McNelis, J. C., & Olefsky, J. M. (01 October 2018). N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model. Bioorganic and Medicinal Chemistry, 26 (18), 5169 - 5180. doi:10.1016/j.bmc.2018.09.015

Ferain, T., Hoveyda, H., Ooms, F., Schols, D., Bernard, J., & Fraser, G. (June 2011). Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication. Journal of Pharmacology and Experimental Therapeutics, 337 (3), 655 - 662. doi:10.1124/jpet.111.179622

Frédérick, R., Dumont, W., Ooms, F., Aschenbach, L., Van der Schyf, C. J., Castagnoli, N., Wouters, J., & Krief, A. (15 June 2006). Synthesis, structural reassignment, and biological activity of type B MAO inhibitors based on the 5H-indeno[1,2-c]pyridazin-5-one core. Journal of Medicinal Chemistry, 49 (12), 3743 - 3747. doi:10.1021/jm051091j

Frédérick, R., Norberg, B., Durant, F., Ooms, F., & Wouters, J. (September 2004). Three 5H-indeno[1,2-c]pyridazin-5-one derivatives, potent type-B monoamine oxidase inhibitors. Acta Crystallographica. Section C, Crystal Structure Communications, 60 (Pt 9), 623 - o626. doi:10.1107/S0108270104014660

Ooms, F., Frédérick, R., Durant, F., Petzer, J. P., Castagnoli, N., Van der Schyf, C. J., & Wouters, J. (06 January 2003). Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative. Bioorganic and Medicinal Chemistry Letters, 13 (1), 69 - 73. doi:10.1016/s0960-894x(02)00838-7

Ooms, F., Weber, P., Carrupt, P. A., & Testa, B. (18 July 2002). A simple model to predict blood-brain barrier permeation from 3D molecular fields. Biochimica et Biophysica Acta, 1587 (2-3), 118 - 125. doi:10.1016/s0925-4439(02)00074-1

Ooms, F., Wouters, J., Oscari, O., Happaerts, T., Bouchard, G., Carrupt, P.-A., Testa, B., & Lambert, D. M. (25 April 2002). Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling. Journal of Medicinal Chemistry, 45 (9), 1748 - 1756. doi:10.1021/jm010896y

Brühlmann, C., Ooms, F., Carrupt, P.-A., Testa, B., Catto, M., Leonetti, F., Altomare, C., & Carotti, A. (13 September 2001). Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. Journal of Medicinal Chemistry, 44 (19), 3195 - 3198. doi:10.1021/jm010894d

Wouters, J., & Ooms, F. (May 2001). Small molecule crystallography in drug design. Current Pharmaceutical Design, 7 (7), 529 - 545. doi:10.2174/1381612013397889

Ooms, F. (February 2000). Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry. Current Medicinal Chemistry, 7 (2), 141 - 158. doi:10.2174/0929867003375317

Ooms, F., Delvosal, S., Wouters, J., Durant, F., Dockendolf, G., Van't Land, C., Glass, T., Castagnoli Jr., N., & Van Der Schyf, C. J. (2000). Empirical and molecular modeling study of the pyridinium species RHPP+, an abundant and potentially neurotoxic metabolite of haloperidol. Journal of the Chemical Society. Perkin Transactions 2, (9), 1781 - 1787. doi:10.1039/b002357o

Ooms, F., Jegham, S., George, P., Durant, F., & Wouters, J. (2000). Molecular interaction between reversible MAO-A inhibitors and the enzyme. Application to aryloxazolidinone, a prototype series. Neurobiology, 8 (1), 81 - 98.

Ooms, F., Wouters, J., Collin, S., Durant, F., Jegham, S., & George, P. (02 June 1998). Molecular lipophilicity potential by CLIP, a reliable tool for the description of the 3D distribution of lipophilicity: application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors. Bioorganic and Medicinal Chemistry Letters, 8 (11), 1425 - 1430. doi:10.1016/s0960-894x(98)00230-3

Bousbaa, J., Ooms, F., & Krief, A. (27 October 1997). γ-Siloxy-benzyllithiums: Stereochemistry of the retro-[1,4]-Brook rearrangement. Tetrahedron Letters, 38 (43), 7625 - 7628. doi:10.1016/S0040-4039(97)01810-8

Wouters, J., Ooms, F., & Durant, F. (15 July 1997). 2-oxazolidinone. Acta Crystallographica. Section C, Crystal Structure Communications, 53 (7), 895 - 897. doi:10.1107/S0108270197003752

Ooms, F., Wouters, J., Durant, F., Castagnoli Jr., N., Van't Land, C., Dockendolf, G., Glass, T., & Van Der Schyf, C. J. (1997). Conformational distribution of the potentially neurotoxic metabolite of haloperidol, HPP+, by NMR spectroscopy, X-ray crystallography and molecular dynamics simulations. Journal of the Chemical Society. Perkin Transactions 2, (12), 2627 - 2632. doi:10.1039/a705037b

Wouters, J., Ooms, F., Jegham, S., Koenig, J. J., George, P., & Durant, F. (1997). Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compounds. European Journal of Medicinal Chemistry, 32 (9), 721 - 730. doi:10.1016/S0223-5234(97)88914-3

Ooms, F., & Pirnay, F. (2024). Pokemón: Ethias’ corporate entrepreneurship initiative. In J. Schmutzler, L. Palacios-Chacón, S. Burvill, ... V. Andonova (Eds.), Teaching Cases on Entrepreneurship and Innovation: Unexplored Topics and Contexts. United States: Edward Elgar. doi:10.4337/9781802204537.00020

Ooms, F., & Falize, M. (2016). Le Business Model Canvas. In F. Janssen, Entreprendre-Une introduction à l'entrepreneuriat (2ième édition). Louvain-La-Neuve, Belgium: De Boeck Supérieur.

Ooms, F. (10 January 2022). Neuroentrepreneurship a call from the discipline: nascent evidence from resting-state fMRI [Paper presentation]. Giga CRC group meeting, Liège, Belgium.

Ooms, F. (16 November 2021). Décrypter le cerveau entrepreneurial [Paper presentation]. Le Grand Saut, Canada.

Ooms, F., Lerner, D., Pollack, J., & Surlemont, B. (28 October 2021). Beyond Entry: Exploring Entrepreneurs’ Self-Reported ADHD Symptoms in Nascent, Early, and Established Ventures [Paper presentation]. Belgian Entrepreneurship Research Day BERD2021, Hasselt, Belgium.

Antony, H., Alâadany, E., Le Petit, M., Ooms, F., & Collette, F. (30 May 2024). Decoding entrepreneurial decision-making through eye tracking: Preliminary Results [Poster presentation]. The Annual Conference of Belgian Association for Psychological Sciences (BAPS), Brussels, Belgium.

Ooms, F., Collette, F., Laureys, S., & Surlemont, B. (August 2023). Navigating the entrepreneurial mind: the influence of stress and well-being on cognitive flexibility [Poster presentation]. Academy of Management, Boston, United States.

Ooms, F., & Mastrogiorgio, A. (17 June 2023). Intrinsic brain activity in organizational neuroscience [Poster presentation]. Academy Of Management - Organizational Neuroscience, Rotterdam, Netherlands.

Ooms, F., & Pollack, J. (05 August 2022). Entrepreneur stress and cognitive Flexibility [Poster presentation]. AOM 2022 Seattle, Seattle, United States.

Magnier, L., & Ooms, F. (2023). L’entrepreneuriat : du profit à la planète. La Libre Belgique.

Ooms, F., & Surlemont, B. (2023). Entrepreneurs : un cerveau différent ? Cerveau & Psycho, (159).

Ooms, F., & Surlemont, B. (2022). Pour un entrepreneuriat à impact. La Libre Belgique.

Ooms, F., & Céline, L. (2021). Avoir deux mains droites. Libre Eco.

Ooms, F. (2024). Unlocking the Entrepreneurial Brain: New Perspectives on Cognitive Flexibility [Paper presentation]. Odoo experience 2024, Bruxelles, Belgium.